Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Research brief

Built environment, biological age and cognition in ALSPAC adolescents

In ALSPAC, childhood built-environment features showed no consistent association with epigenetic or brain age in adolescence; a negative cognition link appeared only in Generation R. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Urban features have been linked to poor psychiatric health in adulthood, but little is known about biological age and cognition earlier in life. [1]

  2. In ALSPAC, the built environment was not associated with epigenetic ages or brain age. [1]

  3. A negative association with cognition was observed in Generation R, and the authors suggest these relationships may emerge in later life. [1]

The source at a glance

Study type / format
Observational longitudinal association study (abstract)
Population / context
Adolescents in the Avon Longitudinal Study of Parents and Children (ALSPAC), with replication in Generation R and triangulation in the Millennium Cohort Study.
Summary based on
Study abstract
Publication status
Preprint · peer-review status not confirmed
Original publication
October 11, 2026

ALSPAC tests urbanicity against three biological age measures

The authors note that urban features have been linked to poor psychiatric health in adulthood, but little is known about biological age and cognition earlier in life. Using the Avon Longitudinal Study of Parents and Children (ALSPAC), they tested associations between the built environment and three epigenetic ages (EpiAge Altum, Horvath and PACE; n=2,452), brain age (n=751) and cognition (n=12,199). These are observational association analyses, not tests of cause.

Supporting source [1]

No association with epigenetic or brain age in ALSPAC

The built environment was not associated with epigenetic ages: effect estimates for Altum ranged 0.013–0.015 (p .466–.689), for Horvath −0.011–0.023 (p .182–.728) and for PACE −0.045–0.013 (p .131–.524). Brain age also showed no association (estimates 0.022–0.028, p .337–.429). The authors conclude there is no consistent evidence that childhood built-environment exposure relates to biological age and cognition in adolescence.

Supporting source [1]

Replication in Generation R and Millennium Cohort

Analyses were replicated in Generation R and triangulated in the Millennium Cohort Study. A negative association with cognition was observed in Generation R. The authors suggest these relationships may emerge in later life. Because this is an abstract, the full text was not reviewed, and details of exposure measurement, follow-up and adjustment are not reported here.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Exposure measurement, follow-up length, adjustment and replication details are not reported. Associations are not causal; the cognition finding appeared in Generation R only.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Longitudinal Associations between the Built Environment, Biological Aging and Cognition

Sanders F, Baltramonaityte V, Staginnus M, Mulder RH, Muetzel RL, Vrijheid M, Dunn EC, Fisher HL, Cecil CA, Walton E. · europepmc.org · October 11, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    little is known about their relationship with
  2. Finding 2 ↑

    The built environment was not associated with
  3. Finding 3 ↑

    A negative association with cognition was observed

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…